Literature DB >> 19776757

EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization.

S Goyama1, E Nitta, T Yoshino, S Kako, N Watanabe-Okochi, M Shimabe, Y Imai, K Takahashi, M Kurokawa.   

Abstract

The ecotropic viral integration site-1 (EVI-1) is a nuclear transcription factor and has an essential function in the proliferation/maintenance of haematopoietic stem cells. Aberrant expression of EVI-1 has been frequently found in myeloid leukaemia as well as in several solid tumours, and is associated with a poor patient survival. It was recently shown that EVI-1 associates with two different histone methyltransferases (HMTs), SUV39H1 and G9a. However, the functional roles of these HMTs in EVI-1-mediated leukemogenesis remain unclear. In this study, we showed that EVI-1 physically interacts with SUV39H1 and G9a, but not with Set9. Immunofluorescence analysis revealed that EVI-1 colocalizes with these HMTs in nuclei. We also found that the catalytically inactive form of SUV39H1 abrogates the transcriptional repression mediated by EVI-1, suggesting that SUV39H1 is actively involved in EVI-1-mediated transcriptional repression. Furthermore, RNAi-based knockdown of SUV39H1 or G9a in Evi-1-expressing progenitors significantly reduced their colony-forming activity. In contrast, knockdown of these HMTs did not impair bone marrow immortalization by E2A/HLF. These results indicate that EVI-1 forms higher-order complexes with HMTs, and this association has a role in the transcription repression and bone marrow immortalization. Targeting these HMTs may be of therapeutic benefit in the treatment for EVI-1-related haematological malignancies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776757     DOI: 10.1038/leu.2009.202

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  31 in total

1.  Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression.

Authors:  Guoyu Ling; Aarathi Sugathan; Tali Mazor; Ernest Fraenkel; David J Waxman
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

Review 2.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

Review 3.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

4.  Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.

Authors:  Danton Ivanochko; Levon Halabelian; Elizabeth Henderson; Pavel Savitsky; Harshika Jain; Edyta Marcon; Shili Duan; Ashley Hutchinson; Alma Seitova; Dalia Barsyte-Lovejoy; Panagis Filippakopoulos; Jack Greenblatt; Evelyne Lima-Fernandes; Cheryl H Arrowsmith
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

5.  A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells.

Authors:  Masoud Vedadi; Dalia Barsyte-Lovejoy; Feng Liu; Sylvie Rival-Gervier; Abdellah Allali-Hassani; Viviane Labrie; Tim J Wigle; Peter A Dimaggio; Gregory A Wasney; Alena Siarheyeva; Aiping Dong; Wolfram Tempel; Sun-Chong Wang; Xin Chen; Irene Chau; Thomas J Mangano; Xi-Ping Huang; Catherine D Simpson; Samantha G Pattenden; Jacqueline L Norris; Dmitri B Kireev; Ashutosh Tripathy; Aled Edwards; Bryan L Roth; William P Janzen; Benjamin A Garcia; Arturas Petronis; James Ellis; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Jian Jin
Journal:  Nat Chem Biol       Date:  2011-07-10       Impact factor: 15.040

6.  EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.

Authors:  Eric M J Bindels; Marije Havermans; Sanne Lugthart; Claudia Erpelinck; Elizabeth Wocjtowicz; Andrei V Krivtsov; Elwin Rombouts; Scott A Armstrong; Erdogan Taskesen; Jurgen R Haanstra; H Berna Beverloo; Hartmut Döhner; Wendy A Hudson; John H Kersey; Ruud Delwel; Ashish R Kumar
Journal:  Blood       Date:  2012-05-02       Impact factor: 22.113

7.  NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science.

Authors:  Mitchell S Cairo; Craig T Jordan; Carlo C Maley; Clifford Chao; Ari Melnick; Scott A Armstrong; Warren Shlomchik; Jeff Molldrem; Soldano Ferrone; Crystal Mackall; Laurence Zitvogel; Michael R Bishop; Sergio A Giralt; Carl H June
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-12       Impact factor: 5.742

8.  Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease.

Authors:  A Herrera-Merchan; L Arranz; J M Ligos; A de Molina; O Dominguez; S Gonzalez
Journal:  Nat Commun       Date:  2012-01-10       Impact factor: 14.919

9.  Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.

Authors:  Feng Liu; Dalia Barsyte-Lovejoy; Abdellah Allali-Hassani; Yunlong He; J Martin Herold; Xin Chen; Christopher M Yates; Stephen V Frye; Peter J Brown; Jing Huang; Masoud Vedadi; Cheryl H Arrowsmith; Jian Jin
Journal:  J Med Chem       Date:  2011-08-05       Impact factor: 7.446

10.  Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.

Authors:  Feng Liu; Dalia Barsyte-Lovejoy; Fengling Li; Yan Xiong; Victoria Korboukh; Xi-Ping Huang; Abdellah Allali-Hassani; William P Janzen; Bryan L Roth; Stephen V Frye; Cheryl H Arrowsmith; Peter J Brown; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2013-10-31       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.